Cardiol Therapeutics Inc (CRDL)
1.99
+0.01
(+0.51%)
USD |
NASDAQ |
May 03, 16:00
1.99
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Total Assets (Quarterly): 27.67M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.67M |
| September 30, 2023 | 31.67M |
| June 30, 2023 | 35.59M |
| March 31, 2023 | 38.95M |
| December 31, 2022 | 45.70M |
| September 30, 2022 | 49.99M |
| June 30, 2022 | 57.64M |
| March 31, 2022 | 63.62M |
| December 31, 2021 | 68.92M |
| September 30, 2021 | 24.88M |
| June 30, 2021 | 29.64M |
| March 31, 2021 | 16.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 12.46M |
| September 30, 2020 | 18.27M |
| June 30, 2020 | 20.08M |
| March 31, 2020 | 9.414M |
| December 31, 2019 | 11.87M |
| September 30, 2019 | 13.83M |
| June 30, 2019 | 15.64M |
| March 31, 2019 | 17.16M |
| December 31, 2018 | 18.12M |
| September 30, 2018 | 10.13M |
| December 31, 2017 | 2.561M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.414M
Minimum
Mar 2020
68.92M
Maximum
Dec 2021
31.19M
Average
27.67M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 548.06M |
| Acasti Pharma Inc | 76.18M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.373M |
| Shareholders Equity (Quarterly) | 21.29M |